How we treat oral chronic graft-versus-host disease
Nathaniel S. Treister(Brigham and Women's Hospital), Leslie Lehmann(Harvard University), Corey Cutler(Harvard University), Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)
Cited by 102
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
|New England Journal of Medicine|2016|595
Hematopoietic Stem-Cell Gene Therapy for Cerebral Adrenoleukodystrophy
|New England Journal of Medicine|2017|592
Hyponatremia among Runners in the Boston Marathon
|New England Journal of Medicine|2005|553
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
|Biology of Blood and Marrow Transplantation|2005|458